Brian S. Lucas

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for modulating splicing
- Patent number 11,964,971
- Issue date Apr 23, 2024
- SKYHAWK THERAPEUTICS, INC.
- Michael Luzzio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for modulating splicing
- Patent number 11,845,744
- Issue date Dec 19, 2023
- SKYHAWK THERAPEUTICS, INC.
- Michael Luzzio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydronaphthalene derivatives useful as Nrf2 activators
- Patent number 11,465,963
- Issue date Oct 11, 2022
- Biogen MA Inc.
- Andrew George Capacci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IRAK4 inhibiting agents
- Patent number 11,427,561
- Issue date Aug 30, 2022
- Biogen MA Inc.
- Timothy Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors...
- Patent number 11,203,601
- Issue date Dec 21, 2021
- The Broad Institute, Inc.
- Florence Fevrier Wagner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that inhibit Mcl-1 protein
- Patent number 11,001,598
- Issue date May 11, 2021
- Amgen Inc.
- Brian S. Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NRF2 activator
- Patent number 10,968,181
- Issue date Apr 6, 2021
- Biogen MA Inc.
- Brian Stuart Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibit MCL-1 protein
- Patent number 10,836,779
- Issue date Nov 17, 2020
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IRAK4 inhibiting agents
- Patent number 10,577,367
- Issue date Mar 3, 2020
- Biogen MA Inc.
- Timothy Chan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IRAK4 inhibiting agents
- Patent number 10,246,456
- Issue date Apr 2, 2019
- Biogen MA Inc.
- Timothy Chan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibit Mcl-1 protein
- Patent number 10,100,063
- Issue date Oct 16, 2018
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 9,873,701
- Issue date Jan 23, 2018
- Amgen Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 9,873,704
- Issue date Jan 23, 2018
- Amgen Inc.
- Minna Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes of making and crystalline forms of a MDM2 inhibitor
- Patent number 9,801,867
- Issue date Oct 31, 2017
- Amgen Inc.
- Matthew Bio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes of making and crystalline forms of a MDM2 inhibitor
- Patent number 9,623,018
- Issue date Apr 18, 2017
- Amgen Inc.
- Matthew Bio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,593,129
- Issue date Mar 14, 2017
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,296,736
- Issue date Mar 29, 2016
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,901,135
- Issue date Dec 2, 2014
- Amgen Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,835,432
- Issue date Sep 16, 2014
- Amgen Inc.
- Minna Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,759,371
- Issue date Jun 24, 2014
- Amgen Inc.
- Brian Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,716,290
- Issue date May 6, 2014
- Amgen Inc.
- Minna Bui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,586,739
- Issue date Nov 19, 2013
- Amgen Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridopyridazine compounds, compositions and methods of use
- Patent number 8,222,251
- Issue date Jul 17, 2012
- Amgen Inc.
- Jacob Kaizerman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,193,199
- Issue date Jun 5, 2012
- Amgen Inc.
- Yi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phthalazine compounds, compositions and methods of use
- Patent number 8,153,633
- Issue date Apr 10, 2012
- Amgen Inc.
- Richard J. Austin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20240300892
- Publication date Sep 12, 2024
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NRF2 ACTIVATOR
- Publication number 20240279197
- Publication date Aug 22, 2024
- Biogen MA Inc.
- Andrew George Capacci
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230331718
- Publication date Oct 19, 2023
- SKYHAWK THERAPEUTICS, INC.
- Michael Luzzio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20230301974
- Publication date Sep 28, 2023
- Amgen Inc.
- Matthew BIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20230271981
- Publication date Aug 31, 2023
- Amgen Inc.
- Brian S. LUCAS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING
- Publication number 20230227474
- Publication date Jul 20, 2023
- SKYHAWK THERAPEUTICS, INC.
- MICHAEL LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230067064
- Publication date Mar 2, 2023
- SKYHAWK THERAPEUTICS, INC.
- MICHAEL LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230069804
- Publication date Mar 2, 2023
- SKYHAWK THERAPEUTICS, INC.
- Michael Luzzio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230068499
- Publication date Mar 2, 2023
- SKYHAWK THERAPEUTICS, INC.
- MICHAEL LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230054781
- Publication date Feb 23, 2023
- SKYHAWK THERAPEUTICS, INC.
- MICHAEL LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230027684
- Publication date Jan 26, 2023
- SKYHAWK THERAPEUTICS, INC.
- Michael LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230020922
- Publication date Jan 19, 2023
- SKYHAWK THERAPEUTICS, INC.
- MICHAEL LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230009712
- Publication date Jan 12, 2023
- Michael Luzzio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20230008867
- Publication date Jan 12, 2023
- SKYHAWK THERAPEUTICS, INC.
- Michael LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20220280496
- Publication date Sep 8, 2022
- Amgen Inc.
- Matthew BIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20220169611
- Publication date Jun 2, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS...
- Publication number 20220112216
- Publication date Apr 14, 2022
- THE BROAD INSTITUTE, INC.
- Florence Fevrier Wagner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20220048890
- Publication date Feb 17, 2022
- SKYHAWK THERAPEUTICS, INC.
- MICHAEL LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20220048902
- Publication date Feb 17, 2022
- SKYHAWK THERAPEUTICS, INC.
- Michael LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NRF2 ACTIVATOR
- Publication number 20220048884
- Publication date Feb 17, 2022
- Biogen MA Inc.
- Andrew George Capacci
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
- Publication number 20220041599
- Publication date Feb 10, 2022
- SKYHAWK THERAPEUTICS, INC.
- MICHAEL LUZZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NRF2 ACTIVATOR
- Publication number 20210387960
- Publication date Dec 16, 2021
- Biogen MA Inc.
- Andrew George Capacci
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NRF2 ACTIVATOR
- Publication number 20210340107
- Publication date Nov 4, 2021
- Biogen MA Inc.
- Brian Stuart Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IRAK4 INHIBITING AGENTS
- Publication number 20210188809
- Publication date Jun 24, 2021
- Biogen MA Inc.
- Timothy Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20210179560
- Publication date Jun 17, 2021
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20210040120
- Publication date Feb 11, 2021
- Amgen Inc.
- Brian S. LUCAS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDRONAPHTHALENE DERIVATIVES USEFUL AS NRF2 ACTIVATORS
- Publication number 20200299230
- Publication date Sep 24, 2020
- Biogen MA Inc.
- Andrew George Capacci
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20200281912
- Publication date Sep 10, 2020
- AMGEN IINC.
- Matthew BIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS...
- Publication number 20200109154
- Publication date Apr 9, 2020
- THE BROAD INSTITUTE, INC.
- Florence Fevrier Wagner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20200062780
- Publication date Feb 27, 2020
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY

Brian S. Lucas

Person

Patents Grantslast 30 patents

Methods and compositions for modulating splicing

Methods and compositions for modulating splicing

Tetrahydronaphthalene derivatives useful as Nrf2 activators

IRAK4 inhibiting agents

Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors...

Compounds that inhibit Mcl-1 protein

NRF2 activator

Compounds that inhibit MCL-1 protein

IRAK4 inhibiting agents

IRAK4 inhibiting agents

Compounds that inhibit Mcl-1 protein

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Processes of making and crystalline forms of a MDM2 inhibitor

Processes of making and crystalline forms of a MDM2 inhibitor

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Heterocyclic compounds and their uses

Pyridopyridazine compounds, compositions and methods of use

Heterocyclic compounds and their uses

Phthalazine compounds, compositions and methods of use

Patents Applicationslast 30 patents

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

NRF2 ACTIVATOR

COMPOSITIONS FOR MODULATING SPLICING

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS...

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

NRF2 ACTIVATOR

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

NRF2 ACTIVATOR

NRF2 ACTIVATOR

IRAK4 INHIBITING AGENTS

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

TETRAHYDRONAPHTHALENE DERIVATIVES USEFUL AS NRF2 ACTIVATORS

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS...

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN